The world’s only searchable, sortable database of CAR-T cell therapy companies worldwide that is publicly available.
CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as “living drugs.”
Since the first historic CAR-T approvals in 2017, Kymriah (tisagenlecleucel), Yescarta (axicabtagene ciloleucel), Tecartus (brexucabtagene autoleucel), Breyanzi (lisocabtagene maraleucel), Abecma (idecabtagene vicleucel), Relma-cel (relmacabtagene autoleucel), and Carvykti™ (ciltacabtagene autoleucel) have reached commercialization.
These historic approvals have driven the CAR-T market to staggering new heights and fueled a frenzy of interest into CAR-T cell therapy development. To track the competitors who compose this rapidly expanding market, BioInformant has released a global database of all known CAR-T cell therapy companies—currently 161 worldwide.
We originally developed this database for our own purposes, but more and more of our readers have requested access to it.
CAR-T Company Database
This database features the following information for all known CAR-T market competitors:
Description of CAR-T Involvement
City / State
Link to CAR-T Programs
Use this searchable database of CAR-T companies to:
- Identify global competitors within the CAR-T marketplace
- Quantify CAR-T products in late-stage development
- Reveal preclinical and clinical programs supporting CAR-T development
- Spot regions that are “hotspots” for CAR-T companies
- Identify potential partners and collaborators
It takes our team of analysts hours of research to uncover these CAR-T cell therapy companies from across the globe and requires the translation of sites and clinical trial programs across dozens of languages.
Thankfully, we have a talented, multilingual team who is up to the task of organizing all known CAR-T companies worldwide. Because we continuously update this database to reflect new competitors entering the CAR-T cell therapy marketplace, we are confident that you will find it to be invaluable resource.
Remember, all BioInformant products come with a Greater Than 100% Money Back Guarantee. If the strategies and tools aren’t helpful to you – we’ll cheerfully refund your money, and you can keep the product.